Avet-logo (Avet Logo)
Leflunomide Tablet
Product Images NDC 71335-2832
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Leflunomide (NDC 71335-2832). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-1 (Figure 1)
Figure-2 (Figure 2)
Figure-3 (Figure 3)
Figure-4 (Figure 4)
This text mentions the Change in Functional Ability Measure®, showing improvement measured by HAQ Disability Index using different treatments such as Loflunomide, Methotrexate, Placebo, and Sulfasalazine. The details on the specific changes in functional ability are not mentioned.*
Label (Lbl713352832)
This is a description of a pharmaceutical product containing Leflunomide, USP 20mg per tablet. The text provides storage instructions, including a temperature range of 15°C to 30°C with protection from light. It also includes a warning to keep the product out of the reach of children and mentions the manufacturer, Bryant Ranch Prepack, Inc. and Heritage Pharma Labs Inc.*
Structural-formula (Structural Formula)
Teriflunomide-structural-formula. (Teriflunomide Structural Formula)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
